China’s well-documented rise in prominence in the global supply chain has created an economic engine that now rivals the United States, but now facing stagnating growth, can China innovate into the 21st Century and drive into new territory?
China’s technological ambition is entering a new phase. The next big challenge lies less in external competition than in its own domestic institutions — whether, and how, they can adapt to the pressures created by innovation itself. This is particularly thorny because Beijing’s track record on this front is much more mixed.
For years, China’s rise has been powered by a well-established playbook: technology prioritized and mobilized through industrial policy, infrastructure supercharged by private-sector competitive dynamics, and a vast domestic STEM ecosystem underpinning both. This formula has helped drive advances in AI, semiconductors, electric vehicles, batteries, robotics, biotechnology, and other strategically important sectors. These efforts have produced real gains, including globally competitive firms, highly integrated manufacturing ecosystems, fast commercialization cycles, and geopolitical leverage from China’s dominance across advanced global supply chains. In some sectors, these structural advantages are profound, and their benefits continue to compound.
But the fragility of the model is also increasingly apparent. First, the domestic macro picture is highly uneven, with a widening gap between pockets of strength and broader structural weakness. Second, external conditions are not looking great, as high-value markets are scrutinizing China more closely amid trade tensions, while export controls at the frontier are becoming harder to break through. Third, in some ways, Beijing has picked the low-hanging fruit of its system by scaling existing technologies. Achieving “0-to-1” innovation is much harder, but that is what must come next.
The critical question, therefore, is whether China’s political economy can absorb the consequences of this technology push, and supply what frontier innovation now requires.
The most immediate consequence is that AI and automation will intensify labor-market disruption. China is already experiencing significant unemployment pressures, particularly among young people. Many emerging technologies are labor-saving in nature, which is likely to deepen the strain across a wide range of sectors: automation will weaken the bargaining position of workers in routine manufacturing, logistics, clerical work, and platform services, while also hitting entry-level white-collar jobs — translation, design, customer service, basic programming, accounting, and administrative support — that absorb a disproportionate number of recent graduates.
The proportion of flexible employment, including ride-hailing, food delivery, housekeeping services, and other platform-based or temporary work, has expanded rapidly in recent years. This segment is estimated to employ around 320 million workers in 2026, accounting for more than 40% of China’s workforce. Yet these workers often lack stable incomes and social protections, exposing longstanding weaknesses in the country’s welfare system.
China’s welfare system is still heavily fragmented by locality, hukou status, and employment type. Many informal and flexible workers are not fully covered; and migrant workers, despite being central to China’s economy, still face limited access to urban public services. If technology accelerates labor-market churn, the gaps in the welfare system will become increasingly costly to ignore. Addressing them will require more portable benefits, stronger unemployment insurance, better retraining, and more credible income support.
This is not simply a social issue. It goes to the heart of China’s innovation model. A weak safety net encourages precautionary saving and suppresses household consumption, weakening the market signals that would otherwise guide innovation toward what people actually need.
This explains why innovation cannot be separated from the broader rebalancing agenda. China’s industrial policy has been highly effective at expanding and upgrading supply by mobilizing land, credit, subsidies, infrastructure, tax incentives, and procurement support to build capacity in favored sectors. But without sufficiently strong domestic demand, investment is more likely to follow politically prioritized sectors than market needs, resulting in overinvestment, duplication, price wars, and excess capacity.
China’s EV sector illustrates both sides of this model. State support, local experimentation, infrastructure buildout, and intense competition built a world-leading ecosystem, yet production capacity has expanded faster than domestic demand has compressed margins and created reliance on overseas markets. Similar patterns are visible in solar and batteries, where scale has lowered global costs but also fueled overcapacity and trade tensions.
Ultimately, a more sustainable innovation model requires stronger demand. When consumers play a larger role in allocating resources, innovation is more likely to be pulled toward more organic and efficient areas rather than pushed by administrative priorities.
Achieving China’s technological ambitions also requires capital-market reform. Frontier innovation relies on patient capital: tech firms often require years of large, sustained spending on everything from talent recruitment to computing power before generating revenue, yet China’s financial system remains poorly suited to supporting projects with such long development cycles and high levels of uncertainty. State banks still favor collateral-heavy lending to established borrowers and politically safer projects. Local government guidance funds can mobilize capital, but they are not always prone to taking risks on genuine innovation. China’s equity markets are still thin and lack both the quantity and quality of funding needed to support frontier innovation. They have also been struggling in recent years, dampening investor confidence. Venture capital and private equity have also faced a more difficult fundraising environment as regulatory uncertainty, slower growth, and weak IPO prospects weigh on returns.
Beijing’s recent emphasis on “patient capital” reflects an awareness of this problem. But patient capital cannot simply be created by the party-state. It requires institutional investors with long time horizons, deeper participation from pension and insurance capital, transparent corporate governance, stronger protection for minority shareholders, more predictable listing rules, and a credible bankruptcy system. Frontier innovation fundamentally depends on experimentation, which inevitably involves failure. This is something China’s system is still not fully comfortable with, as financial disruptions can create broader instability and China’s political logic remains stability-first.
This political instinct, if not scaled back, can also constrain private-sector innovative dynamism. The role of the private sector is central. Many of China’s most globally competitive technology firms emerged from intense private-sector competition. BYD, CATL, DJI, Tencent, Alibaba, ByteDance, DeepSeek, and many biotech startups benefited from policy support and favorable market conditions, but their dynamism also depended on a degree of entrepreneurial autonomy.
If private firms perceive regulatory risk as too high, profit margins as politically suspect, or successful firms as likely to be disciplined for becoming too influential, they will rein in their ambitions, as seen in the 2020-2021 crackdown across the platform economy, fintech, and the education sector. This was followed by a sharp contraction in venture capital activity in 2022, and a broader chilling effect on entrepreneurs and investors. Such a climate would weaken the very innovation capacity Beijing wants to strengthen.
Regulatory capacity is ever more important for the next phase of innovation. In the earlier stages of industrial upgrading, the main task was often to build infrastructure, expand capacity, and move firms up the value chain. Frontier sectors, on the other hand, require more sophisticated governance around data access, privacy, safety testing, liability, and standards.
Biotech, in particular, requires credible clinical trial standards, data governance, intellectual property protection, ethical review, and international regulatory acceptance. Yet China’s domestic medical system remains uneven and fragmented across regions, even within the same city. Hospitals run incompatible electronic health record systems, siloing data that clinical trials depend on. The result is slower drug development cycles and higher compliance costs. Similar regulatory challenges are emerging in autonomous vehicles, digital health, fintech, and robotics, where questions of liability and standard-setting are becoming increasingly important.
China has shown it’s capable of quickly adapting its regulatory framework — cutting its innovative drug approval cycle to 60 days is one example. But the broader legal and regulatory system remains patchy. For innovation, predictability matters as much as policy support.
China is not new to overcoming constraints. It has already faced a range of external pressures, including export controls, investment screening, sanctions, and supply-chain restrictions. The country has shown that it can work around and break through many of these barriers. U.S. restrictions on advanced chips, for example, have accelerated domestic substitution, forced firms to find engineering workarounds, and elevated technological self-reliance to be a national priority.
But some of the most important bottlenecks are now domestic.
Of course, this does not mean China’s technology ambitions will fail. If anything, for an authoritarian regime, China has a surprisingly strong record of adaptation under pressure. It also has a strong innovation foundation in its favor, including major advantages in manufacturing depth, infrastructure, applied engineering talent, and speed of commercialization. In sectors where scale and process-driven innovation matter, China will remain highly competitive and even more innovative.
But these advantages cannot by themselves solve weak consumption, labor insecurity, capital-market distortions, or regulatory unpredictability. In fact, if used too aggressively, they can worsen some of these problems by encouraging excess supply, local protectionism, and inefficient investment.
The central issue is that China’s technological ambitions now require a broader, more daring domestic reform agenda, as a truly innovative China will need secure households, confident private firms, patient capital, stronger and more robust demand, and, fundamentally, more predictable politics. These reforms are difficult because they require politically and institutionally challenging shifts. China’s technology push is therefore not only a challenge to the United States. It is also a stress test for China’s own development model.
